位置:首页 > 蛋白库 > GNPTA_DANRE
GNPTA_DANRE
ID   GNPTA_DANRE             Reviewed;        1219 AA.
AC   Q5RGJ8; Q568G1;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 123.
DE   RecName: Full=N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;
DE            EC=2.7.8.17 {ECO:0000250|UniProtKB:Q3T906};
DE   AltName: Full=GlcNAc-1-phosphotransferase subunits alpha/beta;
DE   AltName: Full=Stealth protein gnptab;
DE   AltName: Full=UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta;
DE   Contains:
DE     RecName: Full=N-acetylglucosamine-1-phosphotransferase subunit alpha;
DE   Contains:
DE     RecName: Full=N-acetylglucosamine-1-phosphotransferase subunit beta;
DE   Flags: Precursor;
GN   Name=gnptab; Synonyms=gnpta; ORFNames=si:ch211-234f20.3, zgc:122985;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Tuebingen;
RX   PubMed=23594743; DOI=10.1038/nature12111;
RA   Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C., Muffato M.,
RA   Collins J.E., Humphray S., McLaren K., Matthews L., McLaren S., Sealy I.,
RA   Caccamo M., Churcher C., Scott C., Barrett J.C., Koch R., Rauch G.J.,
RA   White S., Chow W., Kilian B., Quintais L.T., Guerra-Assuncao J.A., Zhou Y.,
RA   Gu Y., Yen J., Vogel J.H., Eyre T., Redmond S., Banerjee R., Chi J., Fu B.,
RA   Langley E., Maguire S.F., Laird G.K., Lloyd D., Kenyon E., Donaldson S.,
RA   Sehra H., Almeida-King J., Loveland J., Trevanion S., Jones M., Quail M.,
RA   Willey D., Hunt A., Burton J., Sims S., McLay K., Plumb B., Davis J.,
RA   Clee C., Oliver K., Clark R., Riddle C., Elliot D., Threadgold G.,
RA   Harden G., Ware D., Begum S., Mortimore B., Kerry G., Heath P.,
RA   Phillimore B., Tracey A., Corby N., Dunn M., Johnson C., Wood J., Clark S.,
RA   Pelan S., Griffiths G., Smith M., Glithero R., Howden P., Barker N.,
RA   Lloyd C., Stevens C., Harley J., Holt K., Panagiotidis G., Lovell J.,
RA   Beasley H., Henderson C., Gordon D., Auger K., Wright D., Collins J.,
RA   Raisen C., Dyer L., Leung K., Robertson L., Ambridge K., Leongamornlert D.,
RA   McGuire S., Gilderthorp R., Griffiths C., Manthravadi D., Nichol S.,
RA   Barker G., Whitehead S., Kay M., Brown J., Murnane C., Gray E.,
RA   Humphries M., Sycamore N., Barker D., Saunders D., Wallis J., Babbage A.,
RA   Hammond S., Mashreghi-Mohammadi M., Barr L., Martin S., Wray P.,
RA   Ellington A., Matthews N., Ellwood M., Woodmansey R., Clark G., Cooper J.,
RA   Tromans A., Grafham D., Skuce C., Pandian R., Andrews R., Harrison E.,
RA   Kimberley A., Garnett J., Fosker N., Hall R., Garner P., Kelly D., Bird C.,
RA   Palmer S., Gehring I., Berger A., Dooley C.M., Ersan-Urun Z., Eser C.,
RA   Geiger H., Geisler M., Karotki L., Kirn A., Konantz J., Konantz M.,
RA   Oberlander M., Rudolph-Geiger S., Teucke M., Lanz C., Raddatz G.,
RA   Osoegawa K., Zhu B., Rapp A., Widaa S., Langford C., Yang F.,
RA   Schuster S.C., Carter N.P., Harrow J., Ning Z., Herrero J., Searle S.M.,
RA   Enright A., Geisler R., Plasterk R.H., Lee C., Westerfield M.,
RA   de Jong P.J., Zon L.I., Postlethwait J.H., Nusslein-Volhard C.,
RA   Hubbard T.J., Roest Crollius H., Rogers J., Stemple D.L.;
RT   "The zebrafish reference genome sequence and its relationship to the human
RT   genome.";
RL   Nature 496:498-503(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-748.
RC   TISSUE=Olfactory epithelium;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   IDENTIFICATION AS A STEALTH PROTEIN, AND PREDICTION OF FUNCTION.
RX   PubMed=16299590; DOI=10.1371/journal.pcbi.0010063;
RA   Sperisen P., Schmid C.D., Bucher P., Zilian O.;
RT   "Stealth proteins: in silico identification of a novel protein family
RT   rendering bacterial pathogens invisible to host immune defense.";
RL   PLoS Comput. Biol. 1:492-499(2005).
RN   [4]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19834066; DOI=10.2353/ajpath.2009.090210;
RA   Flanagan-Steet H., Sias C., Steet R.;
RT   "Altered chondrocyte differentiation and extracellular matrix homeostasis
RT   in a zebrafish model for mucolipidosis II.";
RL   Am. J. Pathol. 175:2063-2075(2009).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LYS-729.
RX   PubMed=23733939; DOI=10.1073/pnas.1308453110;
RA   Qian Y., Flanagan-Steet H., van Meel E., Steet R., Kornfeld S.A.;
RT   "The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-
RT   acetylglucosamine-1-phosphotransferase is a substrate recognition module.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:10246-10251(2013).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF CYS-447 AND CYS-473.
RX   PubMed=25505245; DOI=10.1074/jbc.m114.612507;
RA   Qian Y., van Meel E., Flanagan-Steet H., Yox A., Steet R., Kornfeld S.;
RT   "Analysis of mucolipidosis II/III GNPTAB missense mutations identifies
RT   domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved
RT   in catalytic function and lysosomal enzyme recognition.";
RL   J. Biol. Chem. 290:3045-3056(2015).
CC   -!- FUNCTION: Catalyzes the formation of mannose 6-phosphate (M6P) markers
CC       on high mannose type oligosaccharides in the Golgi apparatus. M6P
CC       residues are required to bind to the M6P receptors (MPR), which mediate
CC       the vesicular transport of lysosomal enzymes to the
CC       endosomal/prelysosomal compartment. {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(4)-[alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(glycan)]-L-
CC         asparaginyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = H(+) +
CC         N(4)-[6-(N-acetyl-alpha-D-glucosaminyl-1-phospho)-alpha-D-mannosyl-
CC         (1->2)-alpha-D-mannosyl-(glycan)]-L-asparaginyl-[protein] + UMP;
CC         Xref=Rhea:RHEA:13581, Rhea:RHEA-COMP:14507, Rhea:RHEA-COMP:14508,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57705, ChEBI:CHEBI:57865,
CC         ChEBI:CHEBI:140357, ChEBI:CHEBI:140369; EC=2.7.8.17;
CC         Evidence={ECO:0000250|UniProtKB:Q3T906};
CC   -!- SUBUNIT: Hexamer of two alpha, two beta and two gamma (GNPTG) subunits;
CC       disulfide-linked. The alpha and/or the beta subunits of the enzyme
CC       constitute the catalytic subunits. {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- SUBCELLULAR LOCATION: [N-acetylglucosamine-1-phosphotransferase subunit
CC       alpha]: Golgi apparatus membrane {ECO:0000250|UniProtKB:Q3T906};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- SUBCELLULAR LOCATION: [N-acetylglucosamine-1-phosphotransferase subunit
CC       beta]: Golgi apparatus membrane {ECO:0000250|UniProtKB:Q3T906}; Single-
CC       pass type II membrane protein {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- DOMAIN: The DMAP1-binding domain mediates substrate recognition. It
CC       specifically recognizes a conformation-dependent protein determinant
CC       present in acid hydrolases. {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- PTM: The alpha- and beta-subunits are generated by a proteolytic
CC       cleavage by mbtps1 protease at the Gln-893-Asp-894 bond.
CC       {ECO:0000250|UniProtKB:Q3T906}.
CC   -!- DISRUPTION PHENOTYPE: Decreased mannose phosphorylation of lysosomal
CC       acid hydrolases, craniofacial and cardiac defects. Impaired development
CC       of pectoral fins and otic vesicles. Craniofacial defects are due to
CC       changes in the timing and localization of both type II collagen and
CC       sox9 expression, suggestive of an accelerated chondrocyte
CC       differentiation program. Increased level of active cathepsin K (ctsk) 3
CC       days post-fertilization (dpf) because of abnormal processing and
CC       activation, leading to morphologic cartilage defects.
CC       {ECO:0000269|PubMed:19834066, ECO:0000269|PubMed:23733939,
CC       ECO:0000269|PubMed:25505245}.
CC   -!- MISCELLANEOUS: Stealth proteins are part of a protein family that is
CC       conserved from bacteria to higher eukaryotes. Family members were first
CC       identified in microbes as proteins that help pathogens to elude the
CC       host innate immune system. Microbial stealth proteins are most likely
CC       involved in the biosynthesis of exopolysaccharides. Stealth proteins
CC       are predicted to function as hexose-1-phosphoryltransferases.
CC   -!- SIMILARITY: Belongs to the stealth family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH92871.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX890572; CAI11844.1; -; Genomic_DNA.
DR   EMBL; BC092871; AAH92871.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_001038233.1; NM_001044768.3.
DR   AlphaFoldDB; Q5RGJ8; -.
DR   SMR; Q5RGJ8; -.
DR   STRING; 7955.ENSDARP00000040444; -.
DR   PaxDb; Q5RGJ8; -.
DR   Ensembl; ENSDART00000121714; ENSDARP00000106477; ENSDARG00000030153.
DR   GeneID; 553365; -.
DR   KEGG; dre:553365; -.
DR   CTD; 79158; -.
DR   ZFIN; ZDB-GENE-030131-4714; gnptab.
DR   eggNOG; ENOG502QQMR; Eukaryota.
DR   GeneTree; ENSGT00390000006747; -.
DR   HOGENOM; CLU_002469_0_0_1; -.
DR   InParanoid; Q5RGJ8; -.
DR   PhylomeDB; Q5RGJ8; -.
DR   PRO; PR:Q5RGJ8; -.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Chromosome 4.
DR   Bgee; ENSDARG00000030153; Expressed in intestine and 26 other tissues.
DR   ExpressionAtlas; Q5RGJ8; baseline.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0003976; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; IMP:UniProtKB.
DR   GO; GO:0060348; P:bone development; IMP:ZFIN.
DR   GO; GO:0046835; P:carbohydrate phosphorylation; ISS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IMP:ZFIN.
DR   GO; GO:0002063; P:chondrocyte development; IMP:ZFIN.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:ZFIN.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; IMP:ZFIN.
DR   GO; GO:0007040; P:lysosome organization; ISS:UniProtKB.
DR   GO; GO:0016256; P:N-glycan processing to lysosome; IMP:UniProtKB.
DR   InterPro; IPR010506; DMAP1-bd.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR041536; GNPTAB_reg.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR031358; Stealth_CR1.
DR   InterPro; IPR021520; Stealth_CR2.
DR   InterPro; IPR031357; Stealth_CR3.
DR   InterPro; IPR031356; Stealth_CR4.
DR   Pfam; PF06464; DMAP_binding; 1.
DR   Pfam; PF18440; GlcNAc-1_reg; 1.
DR   Pfam; PF00066; Notch; 2.
DR   Pfam; PF17101; Stealth_CR1; 1.
DR   Pfam; PF11380; Stealth_CR2; 1.
DR   Pfam; PF17102; Stealth_CR3; 1.
DR   Pfam; PF17103; Stealth_CR4; 1.
DR   SMART; SM01137; DMAP_binding; 1.
DR   SMART; SM00004; NL; 2.
DR   SUPFAM; SSF90193; SSF90193; 1.
DR   PROSITE; PS51912; DMAP1_BIND; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS50258; LNR; 2.
PE   1: Evidence at protein level;
KW   Calcium; Disulfide bond; Glycoprotein; Golgi apparatus; Membrane;
KW   Metal-binding; Reference proteome; Repeat; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..893
FT                   /note="N-acetylglucosamine-1-phosphotransferase subunit
FT                   alpha"
FT                   /id="PRO_0000227883"
FT   CHAIN           894..1219
FT                   /note="N-acetylglucosamine-1-phosphotransferase subunit
FT                   beta"
FT                   /id="PRO_0000227884"
FT   TRANSMEM        27..47
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1180..1200
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REPEAT          443..478
FT                   /note="LNR 1"
FT   REPEAT          508..538
FT                   /note="LNR 2"
FT   DOMAIN          696..804
FT                   /note="DMAP1-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01260"
FT   DOMAIN          970..1005
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          640..666
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        646..661
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         454
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         469
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         472
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         519
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         534
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         537
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   BINDING         983
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         985
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         987
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         994
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   SITE            893..894
FT                   /note="Cleavage; by mbtps1"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        381
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        462
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        554
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        610
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        617
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        645
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        696
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        726
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        823
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        974
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1021
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1029
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1094
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        443..466
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   DISULFID        457..473
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   DISULFID        508..531
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   DISULFID        522..538
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00525"
FT   MUTAGEN         447
FT                   /note="C->Y: Partial loss of function due to loss of UDP-N-
FT                   acetylglucosamine-lysosomal-enzyme N-
FT                   acetylglucosaminephosphotransferase activity toward some
FT                   substrates."
FT                   /evidence="ECO:0000269|PubMed:25505245"
FT   MUTAGEN         473
FT                   /note="C->S: Partial loss of function due to loss of UDP-N-
FT                   acetylglucosamine-lysosomal-enzyme N-
FT                   acetylglucosaminephosphotransferase activity toward some
FT                   substrates."
FT                   /evidence="ECO:0000269|PubMed:25505245"
FT   MUTAGEN         729
FT                   /note="K->N: Loss of function due to loss of UDP-N-
FT                   acetylglucosamine-lysosomal-enzyme N-
FT                   acetylglucosaminephosphotransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23733939"
FT   CONFLICT        92
FT                   /note="I -> T (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="A -> V (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        262
FT                   /note="K -> Q (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        304
FT                   /note="S -> P (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        474
FT                   /note="Q -> QGTA (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        689
FT                   /note="D -> V (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        712
FT                   /note="N -> D (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        740
FT                   /note="D -> A (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        746
FT                   /note="H -> L (in Ref. 2; AAH92871)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1219 AA;  138982 MW;  8073242310E99C90 CRC64;
     MLVVNSLLKL LQRQTYTCLS HRYGLYLCFG GLVLMIVSAF QFGEVVVEWS RDQYHVLFDS
     YRDNVAGKSF QTRLCLPMPI DVVYTWVNGT DINLLKDLRA VRQRLEEEQK ALRERLGKNG
     SEITEAPKGR PECLLSHCIM GPVLVLDPAL PANITVKELP TLSAAFSSAK ELLQVAKPLH
     PSSSVTALLF HSHTEAEKAH ADALKDLLTH SISRGYLTTD KEAPGLVRMH TLAYLSGFPA
     SLKETEQLRV KLPAVVTSKT KKLQLYSEAS IALLHLNTAQ DFTDLTQQAK KNLTLDGKEL
     TVSSAFLFWD LTAISQSKQD EDVSASRFED NEELRYSLRS IEKHAPWVRH IFIVTNGQIP
     SWLNLDNPRV SVVTHQDIFQ NQTHLPTFSS PAIETHIHRI PGLSQKFIYL NDDVMFGKDV
     WPDDFYSHSK GQKVYLTWPV PNCAEGCPGS WIKDGYCDKA CNNSACDWDG GDCQGSSRFG
     GAGGSVIGGG QPWQFAGGLG GLAGMSFCNQ GCANSWLADK FCDQACNVLA CGFDVGDCGQ
     DNLNQLHRIV LRRNQTLYTL PQGELRPYFS FSGLANRVSE AHVADNQVLR HTSVANKWKT
     IHLLLLPGHN ATQIHYNITF QSTDHHDFIM TFSVSVDTRE LPKSNTSTPV RDKEEEPKPT
     VATPEPEVPF EAVPKEKQGP KVREQTHGDV QVPVLNETLL PDEVKIELKK LNEKLMSGDI
     TIKGFNLTKA MLLEPYKEKD QFTLKHEKDK EEKQKLSPVA QLQNERAAAR VKREKGENVD
     QLKPVAPSLV PVQIDDVTTK AQSRLFNIEK PHMFHLLSNL KGNLSKERDS DSEGHLRERP
     TGRRLQFYSD SLNRGFLPWE KRKFFQDLME EVNRLQTELQ YTADRTATGR RLQDTFADSL
     RYVNRLLNAQ FGFTSRKVPA HMPHMIDRLI MQELQDTFPQ EFDKTSSHRV RHSEDMQFAF
     SYFYFLMSAV QQLNISEVFD EIDTDHSGVL SDREIRTLAT RIHELPLSLQ DLTSLEQMLI
     NCSKSLPSNL THLHAVSPTQ EAYYDPSMPP VTKGLVIHCK PITERIHKAF KDQNKYKFEI
     MGEEEIAFKM IRTNVSHVVG QLDDIRKNPR KFICLNDNID HIHKDAGTVK AVLRDFYESM
     FPLPSQFELP REYRNRFLHM TELQEWRIYR DKLKFWTHCV LVTLVVFTVM SFFAEQLVML
     KRWLFPRRRV SKDANPERV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024